A Screening Study Targeting Tumor-specific Antigens
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
The purpose of this study is to identify patients who may be eligible to participate in a separate Phase 2/3 treatment study evaluating an individualized neoantigen vaccine GRANITE for first line (1L) maintenance treatment of metastatic, microsatellite-sable colorectal cancer (MSS-CRC) sponsored by Gritstone bio. This may include the manufacturing of an individualized vaccine, which involves neoantigen prediction and generating a vaccine targeting neoantigens.
创建时间：
2021-12-15
